| Drug Name |
Oxymetholone |
| Drug ID |
BADD_D01647 |
| Description |
Oxymetholone is a synthetic anabolic steroid marketed under the brand name Anapolon by Hoffmann La Roche Limitedand used in the treatment of osteoporosis, anaemia, and as an agent to stimulate muscle growth in malnourished or underdeveloped patients. Anabolic-androgenic steroids (AAS), such as oxymetholone, have been abused by bodybuilders and athletes. The uncontrolled misuse of oxymetholone can lead to a large variety of detrimental effects, the most often reported of which are cardiovascular events. In 2009, no producers of oxymetholone were identified worldwide (SRI 2009), but it was available from 14 suppliers, including 8 U.S. suppliers (ChemSources 2009). |
| Indications and Usage |
Indicated in the treatment of anemias caused by deficient red cell production. Acquired aplastic anemia, congenital aplastic anemia, myelofibrosis and the hypoplastic anemias due to the administration of myelotoxic drugs often respond. Oxymetholone should not replace other supportive measures such as transfusion, correction of iron, folic acid, vitamin B12 or pyridoxine deficiency, antibacterial therapy and the appropriate use of corticosteroids. |
| Marketing Status |
approved; illicit |
| ATC Code |
A14AA05 |
| DrugBank ID |
DB06412
|
| KEGG ID |
D00490
|
| MeSH ID |
D010110
|
| PubChem ID |
5281034
|
| TTD Drug ID |
D0Q6NZ
|
| NDC Product Code |
49803-008; 51552-1592; 63275-9870; 30007-832 |
| UNII |
L76T0ZCA8K
|
| Synonyms |
Oxymetholone | Oxymethalone | Hydroxymetholone | Oxymetholone, (5 alpha,17 alpha)-Isomer | Oxymetholone, (17 beta)-Isomer | Anadrol | Anapolon 50 |
